1 / 1

DTPw-HBV/Hib (n=439)

Primary vaccination study. 585 enrolled and vaccinated. DTPw-HBV/Hib (n=439). Tritanrix -HBV/Hib (n=146). 8 subjects dropped out: 1 non-serious AE 4 protocol violations 2 consent withdrawals 1 moved away. 22 subjects dropped out:

kieran-witt
Télécharger la présentation

DTPw-HBV/Hib (n=439)

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Primary vaccination study 585 enrolled and vaccinated DTPw-HBV/Hib (n=439) Tritanrix-HBV/Hib (n=146) 8 subjects dropped out: 1 non-serious AE 4 protocol violations 2 consent withdrawals 1 moved away 22 subjects dropped out: 1 SAE 1 non-serious AE 2 protocol violations 11 consent withdrawals 5 moved away 2 lost to follow-up 417 completed 138 completed 439 total vaccinated cohort 146 total vaccinated cohort 39 exclusions: 2 administration of forbidden vaccines 10 study vaccine not administered according to protocol 5 non-compliance with vaccination schedule 1 non-compliance with blood sampling schedule 21 essential serological data missing 14 exclusions: 1 administration of forbidden vaccines 3 study vaccine not administered according to protocol 1 non-compliance with blood sampling schedule 9 essential serological data missing 400 ATP cohort for immunogenicity 132 ATP cohort for immunogenicity Booster study 147 enrolled and vaccinated DTPw-HBV/Hib n=113 Tritanrix-HBV/Hib n=34 113 completed 34 completed 113 total vaccinated cohort 34 total vaccinated cohort 3 exclusions: 1 study vaccine not administered ATP 1 essential serological data missing 110 ATP cohort for immunogenicity 34 ATP cohort for immunogenicity

More Related